Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Circ Cardiovasc Qual Outcomes ; 13(7): e006564, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-32683983

RESUMEN

Utilization management strategies, including prior authorization, are commonly used to facilitate safe and guideline-adherent provision of new, individualized, and potentially costly cardiovascular therapies. However, as currently deployed, these approaches encumber multiple stakeholders. Patients are discouraged by barriers to appropriate access; clinicians are frustrated by the time, money, and resources required for prior authorizations, the frequent rejections, and the perception of being excluded from the decision-making process; and payers are weary of the intensive effort to design and administer increasingly complex prior authorization systems to balance value and appropriate use of these treatments. These issues highlight an opportunity to collectively reimagine utilization management as a transparent and collaborative system. This would benefit the entire healthcare ecosystem, especially in light of the shift to value-based payment. This article describes the efforts and vision of the multistakeholder Prior Authorization Learning Collaborative of the Value in Healthcare Initiative, a partnership between the American Heart Association and the Robert J. Margolis, MD, Center for Health Policy at Duke University. We outline how healthcare organizations can take greater utilization management responsibility under value-based contracting, especially under different state policies and local contexts. Even with reduced payer-mandated prior authorization in these arrangements, payers and healthcare organizations will have a continued shared need for utilization management. We present options for streamlining these programs, such as gold carding and electronic and automated prior authorization processes. Throughout the article, we weave in examples from cardiovascular care when possible. Although reimagining prior authorization requires collective action by all stakeholders, it may significantly reduce administrative burden for clinicians and payers while improving outcomes for patients.


Asunto(s)
Enfermedades Cardiovasculares/economía , Enfermedades Cardiovasculares/terapia , Prestación Integrada de Atención de Salud , Costos de la Atención en Salud , Autorización Previa/economía , Seguro de Salud Basado en Valor/economía , Compra Basada en Calidad/economía , Enfermedades Cardiovasculares/diagnóstico , Toma de Decisiones Clínicas , Análisis Costo-Beneficio , Prestación Integrada de Atención de Salud/economía , Prestación Integrada de Atención de Salud/organización & administración , Humanos , Innovación Organizacional , Formulación de Políticas , Autorización Previa/organización & administración , Mejoramiento de la Calidad/economía , Indicadores de Calidad de la Atención de Salud/economía , Participación de los Interesados , Seguro de Salud Basado en Valor/organización & administración , Compra Basada en Calidad/organización & administración
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA